Noile-Immune Biotech ¥3.1 billion global IPO
The shares are listed on the Tokyo Stock Exchange
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Cutia Therapeutics HK$412.9 million IPO
We advised Cutia on its IPO and HKEX listing
ACELYRIN $621 million IPO
The stock is listed on the Nasdaq Global Select Market
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
MedSci Healthcare Holdings HK$608 million IPO
We advised MedSci on its IPO and HKEX listing
ZJLD Group HK$5.3 billion IPO
We advised ZJLD on its IPO and HKEX listing
Beisen Holding HK$155 million IPO
We advised Beisen on its IPO and HKEX listing
SBI Sumishin Net Bank ¥57.2 billion IPO
The shares are listed on the Tokyo Stock Exchange
IONOS Group €447 million IPO
The shares are listed on the Frankfurt Stock Exchange
Kingsoft Cloud dual primary listing on the Hong Kong Stock Exchange
We advised Kingsoft Cloud on its dual primary listing by way of introduction on the HKEX